Hypertrophic cardiomyopathy causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
| Line 133: | Line 133: | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
*[[Aging]] | *[[Aging]] | ||
*[[Atrial myxoma]] | *[[Atrial myxoma]]<ref name="pmid24082380">{{cite journal| author=Abdou M, Hayek S, Williams BR| title=Atrial myxoma in a patient with hypertrophic cardiomyopathy. | journal=Tex Heart Inst J | year= 2013 | volume= 40 | issue= 4 | pages= 462-4 | pmid=24082380 | doi= | pmc=PMC3783132 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24082380 }} </ref> | ||
*[[Cardiofaciocutaneous syndrome]] | *[[Cardiofaciocutaneous syndrome]] | ||
*[[congenital generalized lipodystrophy|Congenital generalized lipodystrophy type 2]] | *[[congenital generalized lipodystrophy|Congenital generalized lipodystrophy type 2]] | ||
*[[Costello syndrome]] | *[[Costello syndrome]] <ref name="pmid9001809">{{cite journal| author=Fukao T, Sakai S, Shimozawa N, Kuwahara T, Kano M, Goto E et al.| title=Life-threatening cardiac involvement throughout life in a case of Costello syndrome. | journal=Clin Genet | year= 1996 | volume= 50 | issue= 4 | pages= 244-7 | pmid=9001809 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9001809 }} </ref> | ||
*[[Cytochrome c oxidase deficiency]] | *[[Cytochrome c oxidase deficiency]] | ||
*[[Diabetes mellitus]] | *[[Diabetes mellitus]] | ||
*Dihydrolipoamide dehydrogenase deficiency | *Dihydrolipoamide dehydrogenase deficiency | ||
*[[Fabry's disease]] | *[[Fabry's disease]]<ref name="pmid18386622">{{cite journal| author=Adam T, Alexandrescu L, Voinea F, Toringhibel M, Hâncu A| title=Fabry's disease. | journal=Rom J Intern Med | year= 2006 | volume= 44 | issue= 4 | pages= 455-64 | pmid=18386622 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18386622 }} </ref> | ||
*[[Familial]] | *[[Familial]] | ||
*[[Friedreich's ataxia]] | *[[Friedreich's ataxia]]<ref name="pmid12417527">{{cite journal| author=Jauslin ML, Wirth T, Meier T, Schoumacher F| title=A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. | journal=Hum Mol Genet | year= 2002 | volume= 11 | issue= 24 | pages= 3055-63 | pmid=12417527 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12417527 }} </ref> | ||
*[[Gene mutation]] | *[[Gene mutation]] | ||
*[[Glycogenosis type 2]] | *[[Glycogenosis type 2]] | ||
| Line 154: | Line 154: | ||
*[[Multiple lentigines syndrome]] | *[[Multiple lentigines syndrome]] | ||
*[[glycogen synthase|Muscle glycogen synthase deficiency]] | *[[glycogen synthase|Muscle glycogen synthase deficiency]] | ||
*[[Myotonic dystrophy]] | *[[Myotonic dystrophy]]<ref name="pmid17603429">{{cite journal| author=Halawa A, Iskandar SB, Brahmbhatt V, Fahrig SA| title=Atrial flutter and myotonic dystrophy in a male adolescent treated with radiofrequency catheter ablation. | journal=Rev Cardiovasc Med | year= 2007 | volume= 8 | issue= 2 | pages= 118-22 | pmid=17603429 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17603429 }} </ref> | ||
*[[Noonan syndrome]] | *[[Noonan syndrome]]<ref name="pmid24534818">{{cite journal| author=Prendiville TW, Gauvreau K, Tworog-Dube E, Patkin L, Kucherlapati RS, Roberts AE et al.| title=Cardiovascular disease in Noonan syndrome. | journal=Arch Dis Child | year= 2014 | volume= 99 | issue= 7 | pages= 629-34 | pmid=24534818 | doi=10.1136/archdischild-2013-305047 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24534818 }} </ref> | ||
*Sarcomeric protein mutations | *Sarcomeric protein mutations | ||
*Subendocardial ischemia | *Subendocardial ischemia | ||
*[[Thyroid disease]] | *[[Thyroid disease]] | ||
*[[Very long-chain acyl-CoA dehydrogenase deficiency]] | *[[Very long-chain acyl-CoA dehydrogenase deficiency]]<ref name="pmid24530811">{{cite journal| author=Tucci S, Flögel U, Hermann S, Sturm M, Schäfers M, Spiekerkoetter U| title=Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice. | journal=Biochim Biophys Acta | year= 2014 | volume= 1842 | issue= 5 | pages= 677-85 | pmid=24530811 | doi=10.1016/j.bbadis.2014.02.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24530811 }} </ref> | ||
*[[Yunis-Varon syndrome]] | *[[Yunis-Varon syndrome]] | ||
Revision as of 02:46, 3 November 2014
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy causes On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Hypertrophic cardiomyopathy is a condition that is most often passed down through families (inherited). It is thought to result from gene mutations that control heart muscle growth.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
- Aging
- Atrial myxoma[1]
- Cardiofaciocutaneous syndrome
- Congenital generalized lipodystrophy type 2
- Costello syndrome [2]
- Cytochrome c oxidase deficiency
- Diabetes mellitus
- Dihydrolipoamide dehydrogenase deficiency
- Fabry's disease[3]
- Familial
- Friedreich's ataxia[4]
- Gene mutation
- Glycogenosis type 2
- Hereditary spherocytosis
- Hypertension
- Hypertrichotic osteochondrodysplasia
- Idiopathic
- Long-chain acyl-CoA dehydrogenase deficiency
- Malonyl-CoA decarboxylase deficiency
- MELAS
- Multiple lentigines syndrome
- Muscle glycogen synthase deficiency
- Myotonic dystrophy[5]
- Noonan syndrome[6]
- Sarcomeric protein mutations
- Subendocardial ischemia
- Thyroid disease
- Very long-chain acyl-CoA dehydrogenase deficiency[7]
- Yunis-Varon syndrome
References
- ↑ Abdou M, Hayek S, Williams BR (2013). "Atrial myxoma in a patient with hypertrophic cardiomyopathy". Tex Heart Inst J. 40 (4): 462–4. PMC 3783132. PMID 24082380.
- ↑ Fukao T, Sakai S, Shimozawa N, Kuwahara T, Kano M, Goto E; et al. (1996). "Life-threatening cardiac involvement throughout life in a case of Costello syndrome". Clin Genet. 50 (4): 244–7. PMID 9001809.
- ↑ Adam T, Alexandrescu L, Voinea F, Toringhibel M, Hâncu A (2006). "Fabry's disease". Rom J Intern Med. 44 (4): 455–64. PMID 18386622.
- ↑ Jauslin ML, Wirth T, Meier T, Schoumacher F (2002). "A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy". Hum Mol Genet. 11 (24): 3055–63. PMID 12417527.
- ↑ Halawa A, Iskandar SB, Brahmbhatt V, Fahrig SA (2007). "Atrial flutter and myotonic dystrophy in a male adolescent treated with radiofrequency catheter ablation". Rev Cardiovasc Med. 8 (2): 118–22. PMID 17603429.
- ↑ Prendiville TW, Gauvreau K, Tworog-Dube E, Patkin L, Kucherlapati RS, Roberts AE; et al. (2014). "Cardiovascular disease in Noonan syndrome". Arch Dis Child. 99 (7): 629–34. doi:10.1136/archdischild-2013-305047. PMID 24534818.
- ↑ Tucci S, Flögel U, Hermann S, Sturm M, Schäfers M, Spiekerkoetter U (2014). "Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice". Biochim Biophys Acta. 1842 (5): 677–85. doi:10.1016/j.bbadis.2014.02.001. PMID 24530811.